Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Hanley

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Physiology (Bethesda, Md.)|August 14, 2008
Potassium channels keep mobile cells on the goAlbrecht Schwab, Peter Hanley, Anke Fabian, et al.
Cancers|July 9, 2022
Second Generation Small Molecule Inhibitors of Gankyrin for the Treatment of Pediatric Liver CancerAmber M D'Souza, Manu Gnanamony, Maria Thomas, et al.
Journal of the American College of Cardiology|April 20, 2004
Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe anginaBernard R Chaitman, Sandra L Skettino, John O Parker, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Physiology (Bethesda, Md.)|August 14, 2008
Potassium channels keep mobile cells on the goAlbrecht Schwab, Peter Hanley, Anke Fabian, et al.
Cancers|July 9, 2022
Second Generation Small Molecule Inhibitors of Gankyrin for the Treatment of Pediatric Liver CancerAmber M D'Souza, Manu Gnanamony, Maria Thomas, et al.
Journal of the American College of Cardiology|April 20, 2004
Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe anginaBernard R Chaitman, Sandra L Skettino, John O Parker, et al.
Pageof 1